Iminosulfanone compound as bromodomain protein inhibitor and pharmaceutical composition and medical use thereof
US12030880B2 · kind B2 · utility
0Cited by
2References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 25, 2019 |
| Grant date | Jul 9, 2024 |
| Priority date | — |
| Expiry date | Mar 28, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a iminosulfanone compound represented by formula (I) as a bromodomain protein inhibitor and a pharmaceutically acceptable salt thereof and to a preparation method, pharmaceutical composition, and medical use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.